Detalles de la búsqueda
1.
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Ann Rheum Dis
; 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38816065
2.
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study.
Ann Rheum Dis
; 83(7): 847-857, 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443140
3.
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
Clin Exp Rheumatol
; 42(1): 130-137, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650346
4.
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050029
5.
Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis.
Rheumatol Int
; 43(1): 147-156, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129541
6.
Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study.
Rheumatology (Oxford)
; 61(12): 4863-4874, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293988
7.
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.
Clin Exp Rheumatol
; 40(1): 112-119, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635221
8.
Comprehensive assessment and outcomes of patients with chronic periaortitis.
Clin Exp Rheumatol
; 40(4): 801-810, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349413
9.
Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease.
Turk J Med Sci
; 52(1): 83-88, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161593
10.
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
Turk J Med Sci
; 51(1): 297-308, 2021 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979899
11.
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry.
Clin Exp Rheumatol
; 38(4): 609-614, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31498074
12.
Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease' by Wallace et al.
Ann Rheum Dis
; 82(12): e230, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35817470
13.
Do we consider enough the presence of triggering factors in the evaluation of patients with FMF? Triggering factors are highly prevalent in colchicine-resistant FMF patients.
Intern Emerg Med
; 19(2): 391-397, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103114
14.
Factors influencing the outcomes of non-pharmacological interventions for managing fatigue across the lifespan of people living with musculoskeletal (MSK) conditions: a scoping review protocol.
BMJ Open
; 14(5): e082555, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702081
15.
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.
Int J Rheum Dis
; 27(1): e14967, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057290
16.
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
RMD Open
; 9(3)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37604639
17.
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
RMD Open
; 9(4)2023 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38056919
18.
The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease.
Front Med (Lausanne)
; 10: 1115362, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844210
19.
Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
Immun Inflamm Dis
; 11(12): e1089, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38134320
20.
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry.
Rheumatol Ther
; 10(4): 969-981, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294405